Anatomical Therapeutic Chemical • C02CAN1 • terazosin

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

C01 Cardiac therapy

C02 Antihypertensives

C02A Antiadrenergic agents, centrally acting

C02B Antiadrenergic agents, ganglion-blocking

C02C Antiadrenergic agents, peripherally acting

C02CA Alpha-adrenoreceptor antagonists

C02CA01 prazosin Indicated for: hypertension; benign prostatic hyperplasia

C02CA04 doxazosin Indicated for: hypertension; benign prostatic hyperplasia

C02CA06 urapidil Indicated for: hypertension

C02CAN1 terazosin Indicated for: hypertension; benign prostatic hyperplasia

C02CC Guanidine derivatives

C02D Arteriolar smooth muscle, agents acting on

C02K Other antihypertensives

C02L Antihypertensives and diuretics in combination

C02N Combinations of antihypertensives in atc-gr. C02

C03 Diuretics

C04 Peripheral vasodilators

C05 Vasoprotectives

C07 Beta blocking agents

C08 Calcium channel blockers

C09 Agents acting on the renin-angiotensin system

C10 Lipid modifying agents

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various